account_id none on file
legal_name Grace Therapeutics, Inc.
ticker GRCE
cik 1444192
domain gracetx.com
linkedin_company_url none on file
entry_point_account_id none on file
name Grace Therapeutics Inc.
exchange Nasdaq
sector Health Care
hq Princeton, NJ, United States
sector index/company/sector/health-care/
calls 0 filings 19 executives 4 family 0
why_nownone on file
callsnone on file
filings
DelAversano joined the Company in November 2023 as Vice President, Finance and serves as the principal financial officer and principal accounting officer.
filing / Jul 28, 2026 / receipt
By hosting the Annual Meeting online, we can communicate more effectively with our stockholders, enable increased attendance and participation from locations around the world, reduce costs, and increase overall efficiency and safety for us and our stockholders.
filing / Jul 28, 2026 / receipt
~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers
ir_statement / Sep 17, 2026 / receipt
~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers
ir_statement / Sep 15, 2026 / receipt
~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers
ir_statement / Sep 15, 2026 / receipt
~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers
ir_statement / Sep 15, 2026 / receipt
~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers
ir_statement / Sep 15, 2026 / receipt
~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers
ir_statement / Sep 15, 2026 / receipt
A reduction in ventilator days is great for the patient in reducing their risk of infections and benefitting their financial bottom line. It’s also good for hospital costs
ir_statement / Aug 8, 2026 / receipt
From an economic standpoint, fewer days in the ICU or on a ventilator certainly could justify the cost of the drug. Even a reduction of a single day is relevant. When it gets to be 2 or 3 days, then i
ir_statement / Aug 8, 2026 / receipt
GTx-104 target product profile is seen as valuable for its improved tolerability, cost savings, and easy IV use - with broad formulary inclusion by P&T committee
ir_statement / Aug 8, 2026 / receipt
HCPs highlighted that even modest reductions in ICU or ventilator time can have a significant impact on hospital costs, suggesting potential to deliver value beyond drug price-particularly given the h
ir_statement / Aug 8, 2026 / receipt
executives
| Brian D. Ford | Chief Financial Officer | - | receipt |
| Michael L. Derby | director | - | receipt |
| Prashant Kohli | Chief Executive Officer | - | receipt |
| R. Loch Macdonald | Chief Medical Officer | - | receipt |
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2023-05-11 | Chief Medical Officer, appointed | sec_8k |
| 2023-04-05 | Chief Executive Officer, appointed | sec_8k |
| 2022-03-25 | director, appointed | sec_8k |
| 2020-09-18 | Chief Financial Officer, appointed | sec_8k |
mcp_package_hint
slug grace-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$